InvestorsHub Logo
Followers 33
Posts 12874
Boards Moderated 0
Alias Born 08/29/2012

Re: WeeZuhl post# 342240

Sunday, 08/23/2020 9:16:26 PM

Sunday, August 23, 2020 9:16:26 PM

Post# of 403467
Nasrat ALREADY stated on the June 2020 conference call that they are going to develop Concerta "up to a point" where they can run a clinical trial ... and that's it.

Read between the lines.

Elite will NOT be waiting for the approval of Concerta AND they won't ever launch it. That will be the job of the company who buys us.

And why is that?

Because Elite is ALREADY having trouble keeping up with SO MUCH demand for both Adderall products that they are having to spend TONS of money upgrading their existing equipment and as well as trying to come up with CLEVER ways to EXPAND their existing facility which is a PERMANENT structure.

2nd shift ALREADY started last year and Lannett is currently quote "working on MULTIPLE contracts".

It's about to be GAME OVER for Elite ... within two years.

And when I say GAME OVER it means BUYOUT.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157814629


The Concerta application is not imminent and FDA approval before CY2022 is extremely unlikely.








"Most people get interested in stocks when everyone else is. The time to get interested is when no one else is. You can't buy what is popular and do well." - Warren Buffett

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News